Sarzuelo, Jovito, JR.. T.
HRN: 21-29-20 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/30/2022
05/06/2022
IV
500mg
Q8
T/C Partial Bowel Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes